Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) SHZ

1.58

+0.02(+1.28%)

Updated at August 15 08:49AM

Currency In CNY

Hubei Biocause Pharmaceutical Co., Ltd.

Address

#122 Yangwan Road

Jingmen, 448000

China

Phone

86 27 6565 1730

Sector

Financial Services

Industry

Insurance - Life

Employees

1765

First IPO Date

November 12, 1996

Key Executives

NameTitlePayYear Born
Mr. Fei LongSecretary of the Board & Non-Independent Director01979
Ms. Wenxia ZhouVice Chairman & GM01972
Mr. Dali ChenChief Financial Officer & Director01962

Description

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.